会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Controlled chemical release of hydrogen sulfide
    • 硫化氢的控制化学释放
    • US09096504B2
    • 2015-08-04
    • US13989971
    • 2011-12-01
    • Ming XianYu Zhao
    • Ming XianYu Zhao
    • A61K31/21C07C381/00A61K31/095A61K31/165A61K31/166C07C327/00
    • C07C381/00A61K31/095A61K31/165A61K31/166C07C327/00
    • Agents of formula: where R1 and R2 vary independently and are acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, arylalkyl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocycle, or heteroatoms; and R3 is H or a member of a ring structure which includes R2, are provided; as are agents of formula: where R1, R2 and R3 vary independently and: R1=OH, OR′, NHR′, NR′R″ (with R′ R″=alkyl, aryl, heteroaryl, etc); R2=acyl, alkyl, aryl, sulfonyl, etc; R3=alkyl, aryl, substituted aryl, heteroaryl, etc; and R4 and R5 are (independently) H, methyl or alkyl, substituted alkyl, aryl, substituted aryl, etc. Methods of using the agents to treat e.g. cardiovascular disease, stroke, shock, injuries caused by hypoxia, male erectile dysfunction, and Alzheimer's are provided.
    • 酰基,磺酰基,磷酰基,烷基,取代的烷基,卤素,芳基,芳基烷基,取代的芳基,杂芳基,烯基,取代的烯基,炔基,取代的炔基,环烷基,杂环或杂原子 ; 并且R3是H或包括R2的环结构的构件; 如下式所示:其中R1,R2和R3独立变化:R1 = OH,OR',NHR',NR'R“(R'R”=烷基,芳基,杂芳基等); R2 =酰基,烷基,芳基,磺酰基等; R3 =烷基,芳基,取代的芳基,杂芳基等; 并且R 4和R 5是(独立地)H,甲基或烷基,取代的烷基,芳基,取代的芳基等。 提供心血管疾病,中风,休克,由缺氧引起的损伤,男性勃起功能障碍和阿尔茨海默病。
    • 2. 发明申请
    • CONTROLLED CHEMICAL RELEASE OF HYDROGEN SULFIDE
    • 硫化氢的控制化学释放
    • US20130253051A1
    • 2013-09-26
    • US13989971
    • 2011-12-01
    • Ming XianYu Zhao
    • Ming XianYu Zhao
    • C07C381/00C07C327/00
    • C07C381/00A61K31/095A61K31/165A61K31/166C07C327/00
    • Agents of formula: where R1 and R2 vary independently and are acyl, sulfonyl, phosphoryl, alkyl, substituted alkyl, halogen, aryl, arylalkyl, substituted aryl, heteroaryl, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, cycloalkyl, heterocycle, or heteroatoms; and R3 is H or a member of a ring structure which includes R2, are provided; as are agents of formula: where R1, R2 and R3 vary independently and: R1=OH, OR′, NHR′, NR′R″ (with R′ R″=alkyl, aryl, heteroaryl, etc); R2=acyl, alkyl, aryl, sulfonyl, etc; R3=alkyl, aryl, substituted aryl, heteroaryl, etc; and R4 and R5 are (independently) H, methyl or alkyl, substituted alkyl, aryl, substituted aryl, etc. Methods of using the agents to treat e.g. cardiovascular disease, stroke, shock, injuries caused by hypoxia, male erectile dysfunction, and Alzheimer's are provided.
    • 酰基,磺酰基,磷酰基,烷基,取代的烷基,卤素,芳基,芳基烷基,取代的芳基,杂芳基,烯基,取代的烯基,炔基,取代的炔基,环烷基,杂环或杂原子 ; 并且R3是H或包括R2的环结构的构件; 其中R 1,R 2和R 3独立地独立地变化:R 1 = OH,OR',NHR',NR'R“(R'R”=烷基,芳基,杂芳基等); R2 =酰基,烷基,芳基,磺酰基等; R3 =烷基,芳基,取代的芳基,杂芳基等; 并且R 4和R 5是(独立地)H,甲基或烷基,取代的烷基,芳基,取代的芳基等。 提供心血管疾病,中风,休克,由缺氧引起的损伤,男性勃起功能障碍和阿尔茨海默病。